Depressive Clinical Trials

1 recruiting

Depressive Trials at a Glance

534 actively recruiting trials for depressive are listed on ClinicalTrialsFinder across 6 cities in 62 countries. The largest study group is Not Applicable with 299 trials, with the heaviest enrollment activity in New York, Boston, and Toronto. Lead sponsors running depressive studies include Massachusetts General Hospital, Centre for Addiction and Mental Health, and The University of Hong Kong.

Treatments under study

About Depressive Clinical Trials

Looking for clinical trials for Depressive? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Depressive trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Depressive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 534 trials

Recruiting
Phase 2

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Major Depressive Disorder (MDD)
Draig Therapeutics Ltd300 enrolled40 locationsNCT07300969
Recruiting
Not Applicable

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

Depressive Disorder, Major
GrayMatters Health Ltd.170 enrolled3 locationsNCT06982820
Recruiting
Phase 2

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Major Depressive DisorderAnxiety Disorders
National Institute of Mental Health (NIMH)3,500 enrolled1 locationNCT00018057
Recruiting
Phase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

DepressionDepression - Major Depressive DisorderDepression in Adults+3 more
Cybin IRL Limited330 enrolled67 locationsNCT06793397
Recruiting
Phase 1Phase 2

Personalized Ultrasonic Brain Stimulation for Depression (R61)

Depression - Major Depressive DisorderMajor Depressive EpisodeTreatment-Resistant Major Depressive Disorder
Brian Mickey30 enrolled1 locationNCT06902298
Recruiting
Not Applicable

Activating Social Resources in Psychotherapy-Seeking Individuals: Effectiveness and Timing of a Social Support Just-in-Time Adaptive Intervention

Depressive SymptomsLonelinessSocial Support
University of Zurich120 enrolled1 locationNCT07471529
Recruiting
Not Applicable

CARED : A Novel Rapid Treatment Paradigm for Depression

Major Depressive Disorder
University of North Carolina, Chapel Hill30 enrolled1 locationNCT07507370
Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+17 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting
Not Applicable

The Impact of Melatonin Lotion on Sleep and Mental Health

Sleep ProblemsDepressive Disorder and Anxiety Disorders
University of Redlands60 enrolled1 locationNCT06768749
Recruiting

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Healthy VolunteerTobacco Use DisorderMigraine+7 more
Yale University200 enrolled2 locationsNCT06624137
Recruiting
Phase 4

Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Major Depressive DisorderChronic Major Depression, Recurrent
University of Texas at Austin50 enrolled1 locationNCT05892744
Recruiting
Not Applicable

Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes

Mood Disorder (Depressive Episodes)
Resilience594 enrolled6 locationsNCT07087353
Recruiting
Phase 2

Mindfulness Engaged Neurostimulation for Depression (MEND II)

DepressionDepressive DisorderDepressive Symptoms+2 more
University of California, San Diego120 enrolled1 locationNCT07512284
Recruiting
Phase 1Phase 2

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

SchizophreniaMajor Depressive DisorderBipolar I Disorder
Mapi Pharma Ltd.24 enrolled6 locationsNCT07185815
Recruiting

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University320 enrolled1 locationNCT07479758
Recruiting

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study

Major Depressive DisorderBipolar DisorderMild Cognitive Impairment
Mayo Clinic200 enrolled1 locationNCT06897670
Recruiting
Phase 2

Neutralizing Interleukin (IL)-6

Major Depressive Disorder
Icahn School of Medicine at Mount Sinai60 enrolled1 locationNCT07493317
Recruiting
Not Applicable

rTMS for Military TBI-related Depression

Depressive SymptomsConcussionMild Traumatic Brain Injury
Henry M. Jackson Foundation for the Advancement of Military Medicine198 enrolled3 locationsNCT05426967
Recruiting
Phase 1

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
Washington University School of Medicine60 enrolled1 locationNCT02994433
Recruiting
Phase 1

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

DepressionHealthy VolunteerMajor Depressive Disorder
National Institute of Mental Health (NIMH)150 enrolled1 locationNCT03065335